Skip to content

Drug interactions

Argatroban + Defibrotide

Severity: Contraindicated

Argatroban and Defibrotide: contraindicated interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Defibrotide has profibrinolytic and antithrombotic activity and, combined with the direct thrombin inhibitor argatroban, may increase hemorrhage risk. Defibrotide labeling contraindicates concomitant systemic anticoagulant or fibrinolytic therapy.

What this interaction means in plain words

Argatroban and Defibrotide are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Argatroban belongs to Cardiovascular; Defibrotide belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Additive antithrombotic and profibrinolytic effects increase bleeding tendency.

What to do

Do not use together; hold argatroban during defibrotide therapy or choose an alternative, except for routine central line maintenance.

What to ask your pharmacist

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Argatroban and Defibrotide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Argatroban with Defibrotide?

MediHelp rates the interaction as contraindicated. Argatroban and Defibrotide are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Defibrotide has profibrinolytic and antithrombotic activity and, combined with the direct thrombin inhibitor argatroban, may increase hemorrhage risk. Defibrotide labeling contraindicates concomitant systemic anticoagulant or fibrinolytic therapy.

How serious is the interaction between Argatroban and Defibrotide?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Do not use together; hold argatroban during defibrotide therapy or choose an alternative, except for routine central line maintenance.

What other medicines interact with Argatroban?

MediHelp also lists interactions of Argatroban with, for example, Ketorolac, Mifepristone, Abciximab. The full list is on the Argatroban page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in